Frequency of mutations of insulin receptor gene in Japanese patients with NIDDM. 1995

M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
Department of Enzyme Genetics, Institute for Enzyme Research, University of Tokushima, Japan.

To examine the prevalence of abnormalities in the insulin receptor structure gene in Japanese with non-insulin-dependent diabetes mellitus (NIDDM), a population of 51 patients with NIDDM was screened for mutations in this gene. Patient genomic DNAs of both alleles corresponding to 22 exons of the gene were amplified by polymerase chain reaction (PCR). The PCR products on pUC19 were sequenced. Three patients with heterozygous missense mutation Thr831-->Ala831 in exon 13 and one patient with heterozygous missense mutation Tyr1334-->Cys1334 in exon 22 of the beta-subunits were identified. Linkage analysis of one of the families plus statistical studies showed that the mutation Thr831-->Ala831 is possibly responsible for the onset of NIDDM. In COS cells transiently expressing both mutant receptor cDNAs and a cDNA of a M(r) 85,000 regulatory subunit of phosphatidylinositol 3-kinase (PI 3-kinase), the mutation Tyr1334-->Cys1334 impaired binding of the receptor with the M(r) 85,000 subunit of PI 3-kinase, but linkage analysis of the family showed that the mutation did not cosegregate with NIDDM in the pedigree. Therefore, one missense mutation (Thr831-->Ala831) in the insulin receptor, as found in three patients, is possibly involved in the etiology of a subset of the 51 NIDDM patients.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008040 Genetic Linkage The co-inheritance of two or more non-allelic GENES due to their being located more or less closely on the same CHROMOSOME. Genetic Linkage Analysis,Linkage, Genetic,Analyses, Genetic Linkage,Analysis, Genetic Linkage,Genetic Linkage Analyses,Linkage Analyses, Genetic,Linkage Analysis, Genetic
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D011972 Receptor, Insulin A cell surface receptor for INSULIN. It comprises a tetramer of two alpha and two beta subunits which are derived from cleavage of a single precursor protein. The receptor contains an intrinsic TYROSINE KINASE domain that is located within the beta subunit. Activation of the receptor by INSULIN results in numerous metabolic changes including increased uptake of GLUCOSE into the liver, muscle, and ADIPOSE TISSUE. Insulin Receptor,Insulin Receptor Protein-Tyrosine Kinase,Insulin Receptor alpha Subunit,Insulin Receptor beta Subunit,Insulin Receptor alpha Chain,Insulin Receptor beta Chain,Insulin-Dependent Tyrosine Protein Kinase,Receptors, Insulin,Insulin Receptor Protein Tyrosine Kinase,Insulin Receptors
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA

Related Publications

M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
April 1992, Diabetes care,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
December 1996, Research communications in molecular pathology and pharmacology,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
June 1991, Diabetes,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
March 1990, Diabetes care,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
October 1994, Nihon rinsho. Japanese journal of clinical medicine,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
April 1995, Diabetologia,
M Kan, and F Kanai, and M Iida, and H Jinnouchi, and M Todaka, and T Imanaka, and K Ito, and Y Nishioka, and T Ohnishi, and S Kamohara
May 1996, Diabetologia,
Copied contents to your clipboard!